Holen Sie sich die Stockscreener-App
8.02
5.98%
-0.51
Handel nachbörslich:
8.16
0.14
+1.75%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ACHV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.53
Offen:
$8.42
24-Stunden-Volumen:
1.45M
Relative Volume:
0.80
Marktkapitalisierung:
$825.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-51.99M
KGV:
-7.1896
EPS:
-1.1155
Netto-Cashflow:
$-45.31M
1W Leistung:
+10.62%
1M Leistung:
+28.53%
6M Leistung:
+87.82%
1J Leistung:
+210.85%
1-Tages-Spanne:
$7.96
$8.46
1-Wochen-Bereich:
$7.15
$8.61
52-Wochen-Spanne:
$2.60
$8.61
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Firmenname
Achieve Life Sciences Inc
Sektor
Branche
Telefon
425-686-1500
Adresse
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
8.02 | 877.76M | 0 | -51.99M | -45.31M | -1.1155 |
VRTX
Vertex Pharmaceuticals Inc
|
540.26 | 139.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
826.64 | 86.57B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,038.12 | 64.62B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
133.32 | 69.62B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.74 | 46.01B | 742.00K | -1.37B | -1.07B | -7.0731 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-11-25 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Strong Buy |
| 2023-05-10 | Bestätigt | Maxim Group | Buy |
| 2021-06-23 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten
Achieve Life (NASDAQ: ACHV) director to sell 20,626 shares - Stock Titan
Achieve Life Sciences (NASDAQ:ACHV) Sets New 12-Month HighShould You Buy? - MarketBeat
Achieve Life Sciences (ACHV) draws new passive holder near 10% - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Achieve Life Sciences Inc (ACHV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Achieve Life Sciences Inc (ACHV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Achieve Life Sciences (NASDAQ:ACHV) Stock Rating Lowered by Wall Street Zen - MarketBeat
Achieve Life SciencesEnters ATM Sale Agreement With Jefferies For Up To $150 Million In Common Stock - TradingView
Achieve Life Sciences (ACHV) launches $150M at-the-market stock program - Stock Titan
Achieve Life Sciences, Inc. (NASDAQ:ACHV): When Will It Breakeven? - Moomoo
Achieve Life Sciences, Inc. (NASDAQ:ACHV): Is Breakeven Near? - simplywall.st
(08/14/26) ACHV: A Speculative Trade in the Biotech Sector - moneyshow.com
Janus Henderson Group (ACHV) reports 5,502,064 Achieve Life shares under management - Stock Titan
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Achieve Life Sciences' Cytisinicline to Unlock $760 Million Market Opportunity in Smoking Cessation, Morgan Stanley Says - marketscreener.com
Achieve Life Sciences, Inc. Stock 12‑Month Price Target Cut to $13.83, Implies 107% Upside - TradingView
Achieve Life Sciences (NASDAQ:ACHV) Hits New 12-Month HighHere's Why - MarketBeat
Achieve stock gains Overweight at Morgan Stanley (ACHV:NASDAQ) - Seeking Alpha
HC Wainwright Has Optimistic Outlook of ACHV Q3 Earnings - MarketBeat
ACHV Initiates Coverage On by Morgan Stanley -- Rating Set to Ov - GuruFocus
Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target - marketscreener.com
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit. - webull.com
Morgan Stanley initiates Achieve Life Sciences stock at overweight By Investing.com - Investing.com Nigeria
Morgan Stanley initiates Achieve Life Sciences stock at overweight - Investing.com
H.C. Wainwright reiterates Achieve Life Sciences stock rating at buy By Investing.com - Investing.com Canada
Research Analysts Set Expectations for ACHV FY2028 Earnings - MarketBeat
Achieve Life Sciences Submits Q2 2026 Form 10-Q Highlighting NDA Resubmission and Financial Risks - Kalkine Media
Achieve Life Sciences Releases Q2 2026 Financial Results - AlphaStreet
ACHIEVE LIFE SCIENCES, INC. 6M 2026: Net loss $(84.9)M, EPS $(1.15) — 10-Q Summary - TradingView
Achieve Life Sciences (ACHV) swings to larger $84.9M loss on warrant costs - stocktitan.net
Achieve Life Sciences (NASDAQ: ACHV) posts larger Q2 2026 loss but secures $354M financing - Stock Titan
Achieve Life Sciences Q2 Results: EPS misses estimate, losses widen - scanx.trade
Achieve Life Sciences (NASDAQ:ACHV) Posts Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat
Achieve Life Sciences (ACHV) Advances Cytisinicline Commercializ - GuruFocus
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - marketscreener.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Achieve Life Sciences (ACHV) - The Globe and Mail
ACHV Q2'26 Earnings: EPS estimate is (0.16) USD - TradingView
Achieve Life Sciences Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Achieve Life Sciences names manufacturing, quality executives - Investing.com
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - marketscreener.com
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality - marketscreener.com
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Achieve Life Sciences (ACHV) Expected to Post Earnings on Thursday - MarketBeat
Achieve Life Sciences (NASDAQ: ACHV) awards options and RSUs to director - Stock Titan
Franklin Resources (ACHV) group discloses 8.3% Achieve Life Sciences stake via funds - Stock Titan
Achieve Life Sciences Inc (ACHV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ACHV|Achieve Life Sciences Inc|Price:6.185|Chg%:+0.085 - TradingKey
BlackRock, Inc. (ACHV) discloses 5.1% beneficial stake in Achieve Life Sciences - Stock Titan
ACHV|Achieve Life Sciences Inc|Price:6.670|Chg%:+0.200 - TradingKey
Achieve Life Sciences Inc (ACHV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):